Correlation Between OpGen and VentriPoint Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OpGen and VentriPoint Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OpGen and VentriPoint Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OpGen Inc and VentriPoint Diagnostics, you can compare the effects of market volatilities on OpGen and VentriPoint Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OpGen with a short position of VentriPoint Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of OpGen and VentriPoint Diagnostics.

Diversification Opportunities for OpGen and VentriPoint Diagnostics

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between OpGen and VentriPoint is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding OpGen Inc and VentriPoint Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VentriPoint Diagnostics and OpGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OpGen Inc are associated (or correlated) with VentriPoint Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VentriPoint Diagnostics has no effect on the direction of OpGen i.e., OpGen and VentriPoint Diagnostics go up and down completely randomly.

Pair Corralation between OpGen and VentriPoint Diagnostics

Given the investment horizon of 90 days OpGen Inc is expected to under-perform the VentriPoint Diagnostics. In addition to that, OpGen is 2.04 times more volatile than VentriPoint Diagnostics. It trades about 0.0 of its total potential returns per unit of risk. VentriPoint Diagnostics is currently generating about 0.0 per unit of volatility. If you would invest  20.00  in VentriPoint Diagnostics on August 24, 2024 and sell it today you would lose (11.42) from holding VentriPoint Diagnostics or give up 57.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy87.3%
ValuesDaily Returns

OpGen Inc  vs.  VentriPoint Diagnostics

 Performance 
       Timeline  
OpGen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OpGen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, OpGen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
VentriPoint Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

OpGen and VentriPoint Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OpGen and VentriPoint Diagnostics

The main advantage of trading using opposite OpGen and VentriPoint Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OpGen position performs unexpectedly, VentriPoint Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VentriPoint Diagnostics will offset losses from the drop in VentriPoint Diagnostics' long position.
The idea behind OpGen Inc and VentriPoint Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
CEOs Directory
Screen CEOs from public companies around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios